$26.50
Manufacturer: Cyprus
Purpose: Cefuroxime targets bacterial infections by inhibiting cell wall synthesis.
Description
Axetin Coated (Cefuroxime) Tablets 500 mg. №10
Ingredients:
Each tablet contains 500 mg of cefuroxime as the active ingredient.
Dosage:
The usual dosage for adults is 250 mg to 500 mg every 12 hours.
Indications:
Axetin coated tablets are indicated for the treatment of various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and urinary tract infections.
Contraindications:
Do not use Axetin tablets if you are allergic to cefuroxime or any other cephalosporin antibiotics.
Directions:
Take Axetin tablets as prescribed by your healthcare provider. Swallow the tablet whole with a full glass of water.
Scientific Evidence:
Cefuroxime, the active ingredient in Axetin tablets, is a second-generation cephalosporin antibiotic with a broad spectrum of antibacterial activity. It works by inhibiting bacterial cell wall synthesis, leading to the death of the bacteria. Clinical studies have shown that cefuroxime is effective in treating various bacterial infections, with a good safety profile.
Additional Information:
Axetin coated tablets should be stored at room temperature away from moisture and heat. Keep out of reach of children. If you experience any severe side effects or allergic reactions, seek medical help immediately.
Pharmacological Effects:
Cefuroxime exerts its pharmacological effects by interfering with the synthesis of the bacterial cell wall, leading to cell lysis and death. This mechanism of action makes it effective against a wide range of Gram-positive and Gram-negative bacteria. Additionally, cefuroxime has shown good tissue penetration, allowing it to reach the site of infection effectively.
Clinical Trials and Comparative Effectiveness:
In a comparative study published in the Journal of Antimicrobial Chemotherapy, cefuroxime was found to be as effective as other commonly used antibiotics in the treatment of community-acquired pneumonia. The study concluded that cefuroxime exhibited similar clinical outcomes and safety profiles, making it a valuable option in the management of respiratory infections.
Recent Reviews